We are live on ! Find out more
Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $209B
1-Year Est. Return 37.72%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Fund
S&P 500
This Quarter Est. Return
+10.7%
1 Year Est. Return
+37.72%
3 Year Est. Return
+117.83%
5 Year Est. Return
+153.46%
10 Year Est. Return
+660.32%
AUM
$192B
AUM Growth
+$13.7B
Cap. Flow
-$2.28B
Cap. Flow %
-1.19%
Top 10 Hldgs %
24%
Holding
1,403
New
105
Increased
521
Reduced
678
Closed
86

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$564M
2
BABA icon
Alibaba
BABA
+$511M
3
MO icon
Altria Group
MO
+$439M
4
RVTY icon
Revvity
RVTY
+$321M
5
MRK icon
Merck
MRK
+$316M

Sector Composition

Rank Sector Weight
1 Technology 30.77%
2 Healthcare 19.73%
3 Consumer Discretionary 11.5%
4 Financials 9.61%
5 Communication Services 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARNC
1376
DELISTED
Arconic Corporation
ARNC
-10,948
Closed -$153K
KDNY
1377
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-51,545
Closed -$594K
BLU
1378
DELISTED
BELLUS Health Inc.
BLU
-232,730
Closed -$2.4M
STSA
1379
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-54,633
Closed -$1.57M
BRMK
1380
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
-11,018
Closed -$104K
ONEM
1381
DELISTED
1Life Healthcare
ONEM
-899,415
Closed -$32.7M
ELAT
1382
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
-155,756
Closed -$6.04M
AKUS
1383
DELISTED
Akouos Inc
AKUS
-203,100
Closed -$4.57M
EPZM
1384
DELISTED
Epizyme, Inc
EPZM
-1,994,235
Closed -$32M
NP
1385
DELISTED
Neenah, Inc. Common Stock
NP
-122,288
Closed -$6.05M
RDS.B
1386
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
-8,168
Closed -$249K
XEC
1387
DELISTED
CIMAREX ENERGY CO
XEC
-9,951
Closed -$274K
BPYU
1388
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
-85,704
Closed -$854K
PS
1389
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
-75,000
Closed -$1.35M
IMMU
1390
DELISTED
Immunomedics Inc
IMMU
-1,320,782
Closed -$46.8M
NBL
1391
DELISTED
Noble Energy, Inc.
NBL
-82,543
Closed -$740K
MNTA
1392
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
-1,488,914
Closed -$49.5M
CCMP
1393
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-227,660
Closed -$31.8M
WUBA
1394
DELISTED
58.com Inc
WUBA
-4,363
Closed -$235K
LOGM
1395
DELISTED
LogMein, Inc.
LOGM
-45,815
Closed -$3.88M
GSB
1396
DELISTED
GlobalSCAPE, Inc.
GSB
-62,460
Closed -$609K
LM
1397
DELISTED
Legg Mason, Inc.
LM
-85,282
Closed -$4.24M
CCI.PRA
1398
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
-140
Closed -$208K
GTYH
1399
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
-2,441,032
Closed -$10.2M
CADE
1400
DELISTED
Cadence Bancorporation
CADE
-10,362
Closed -$92K

Similar funds

Janus Henderson Group's Q3 2020 Portfolio in Review

As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
  • Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
  • Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
  • Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
  • Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
  • Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
  • Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.

Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.